Awards for Scientific Publications

Awards for Scientific Communications

PhD Thesis Awards

Grants

Awards for Scientific Publications

  1. Top-10 most cited articles published in Bioorganic and Medicinal Chemistry Letters (2011-2012), by article “Chromone 3-phenylcarboxamides as potent and selective MAO-B inhibitors”, A. Gaspar, J. Reis, A. Fonseca, N. Milhazes, D. Viña, E. Uriarte, Borges. Bioorg. Med. Chem. Lett., 2011, 21 (2): 707-9.
  2. Top-10 most cited articles published in ChemMedChem (2012), by article “8-Substituted-3-arylcoumarins as potent and selective MAO-B inhibitors: synthesis, pharmacological evaluation and docking studies”, D Viña, MJ Matos, G. Ferino, E Cadoni, R Laguna, F Borges, E Uriarte, L Santana. ChemMedChem 2012, 7, 464-470.
  3. Annual Award of the Cuban Academy of Sciences to the results in the Scientific Research: “From molecular structure biological activity: Applications and potentialities of novel computational design methods in QSAR, QSPR, QSPkR, QSTR studies, proteomic and bioinformatics”
  4. Highly cited paper by web of science (received enough citations to place it in the top 1% of the academic field of Chemistry based on a highly cited threshold for the field and publication year) by article Gaspar, M. J. Matos, J. Garrido, E. Uriarte, F Borges “Chromone: a valid scaffold in medicinal chemistry”, Chem. Rev., 2014, 114 (9), 4960-4992.
  5. Highly cited paper by web of science (received enough citations to place it in the top 1% of the academic field of Chemistry based on a highly cited threshold for the field and publication year) by article M.F. Roleira, E.J. Tavares-da-Silva, C.L. Varela, S.C. Costa, T. Silva, J. Garrido, F. Borges, “Plant derived and dietary phenolic antioxidants: anticancer properties”, Food Chem., 2015, 183, 235-258.
  6. Highly cited paper by web of science (received enough citations to place it in the top 1% of the academic field of Chemistry based on a highly cited threshold for the field and publication year) by article Reis J, Gaspar A, Milhazes N, Borges F.Chromone as a privileged scaffold in drug discovery: recent advances. J Med Chem. 2017, ;60(19), 7941-7957.

Awards for Scientific Communications

Oral Communications

  1. I. M. Oliveira, A. Borges, F. Borges, M. Simões, “The effects of ibuprofen on Staphylococcus aureus biofilm control”, 3rd International Caparica Conference in Antibiotic Resistance (IC2AR). Shotgun Session II, Lisbon (Portugal), 10th-13rd June 2019
  1. F. Mesiti, A. Gaspar, D. Chavarria, C. Fernandes, R. Silva, S. Alcaro, F. Borges, “Mapping the chromone-3-phenylcarboxamide pharmacophore: structure-activity-toxicity and efflux transport studies”, 4th WG meeting – MuTaLig COST Action. Faculty of Pharmacy, Ege University, Izmir (Turkey), 5-6 th March 2020
  1. R. Amorim, J. Teixeira, S. Benfeito, F. Cagide, P.J. Oliveira, F. Borges, “Mitochondriotropic Cinnamic Acid Antioxidant Improves Cellular Resistance to Stress”, 4th WG meeting – MuTaLig COST Action. Faculty of Pharmacy, Ege University, Izmir (Turkey), 5-6th March 2020

Poster Communications

  1. K. Santos, J. Teixeira, R. Amorim, F. Cagide, F. Borges, P.J. Oliveira, “New paradigms in anticancer combined therapy: Targeting dietary antioxidants to mitochondria”, 49th Annual Scientific Meeting of the European Society for Clinical Investigation, Cluj-Napoca (Romania), 27-30th May 2015
  2. S. Benfeito, F. Remião E. Uriarte, F. Borges, “Development of bifunctional agents for ameliorating the oxidative stress associated with aging related diseases”, 36th Edition of the European School of Medicinal Chemistry (ESMEC), Urbino (Italy), June 26th-July 1st 2016
  3. J. Teixeira, R. Amorim, R. Carreira, F. Cagide, S. Benfeito, F. Borges, P.J. Oliveira, “Effects of multi-operational mitochondria-targeted antioxidants in human hepatic cells: promising drugs for liver disease”, 52nd Annual Meeting of the European Society for Clinical Investigation, Barcelona (Spain), 29th May-1st June 2018
  4. P. Soares, C. Oliveira, S. Benfeito, F. Cagide, C. Fernandes, J. Teixeira, R. Amorim, P. J. Oliveira, F. Borges, “From nature inspiration to multitarget small molecules: upgrading the activity of dietary cinnamic and benzoic acids for the treatment of neurodegenerative disorders”, 3rd WG meeting, MuTaLig COST ACTION CA15135, Paris (France), 23-24th February 2019
  5. P. Soares, C. Silva, F. Silva, M. Batie, C. Oliveira, F. Cagide, P.J. Oliveira, S. Rocha, F. Borges,“1-Mitochondriotropic antioxidants as novel therapeutics for Amyotrophic Lateral Sclerosis: development of multitarget agents to prevent stress induced motor neurons death”, 3rd WG meeting, MuTaLig COST ACTION CA15135, Paris (France), 23-24th February 2019
  6. D. Chavarria, C. Fernandes, V. Silva, E. Gil-Martins, R. Silva, F. Remião, P.J. Oliveira and F. Borges, 2-Design and development of piperine derivatives acting as potent MAO-B inhibitors and mild P-gp inhibitors”, 3rd WG meeting, MuTaLig COST ACTION CA15135, Paris (France), 23-24th February 2019

PhD Thesis Awards

2014

  • Chromone: a valid scaffold in medicinal chemistry
    Alexandra Gaspar, University of Porto (Portugal)

2016 

  • Hydroxycinnamic acid as a valid scaffold for the development of CNS multitarget drugs
    Tiago Silva, University of Porto (Portugal)
  • Targeting dietary antioxidants to mitochondria as a therapeutic solution for mitochondrial oxidative stress related diseases
    José Teixeira, University of Porto (Portugal)

2017

  • Discovery of target directed drugs for neurodegenerative diseases based on benzopyrone scaffold
    André Fonseca, University of Porto (Portugal)

2018

  • Benzoic acid as a valid scaffold for the development of dual-target directed drugs for Alzheimer’s disease
    Catarina Oliveira, University of Porto (Portugal)
  • Single and multi-target agents for neurodegenerative diseases based on the chromone scaffold
    Joana Reis, University of Porto (Portugal)

2019

  • Development of PEGylated platforms to overcome blood–brain barrier constraints in neurodegenerative therapy
    Carlos Fernandes, University of Porto (Portugal)
  • Design and development of multi-target agents for neurodegenerative diseases
    Sofia Benfeito, University of Porto (Portugal)

2014

  • Cumarinas: Versatilidade estrutural e aplicacións en Química Farmacéutica
    Maria João Matos, University of Santiago de Compostela

Grants

2010

  • European Federation for Medicinal Chemistry (EFMC) fellowship
    European School of Medicinal Chemistry- ESMEC, Urbino, Italy, 26th June- 1st July, 2010
    Maria João Matos, University of Porto (Portugal)
    Webpage
  • XXI International Symposium on Medicinal Chemistry (EFMC-ISMC) grant
    Brussels, Belgium, 5-9th September, 2010
    Maria João Matos, University of Porto (Portugal)
    Webpage
  • Sociedade Espanhola de Química Terapêutica (SEQT) grant
    IX Jornadas de la SEQT – New perspective and emerging technologies in drug discovery, Baeza, Spain, 11st-12nd November, 2010
    Maria João Matos, University of Porto (Portugal)
    Webpage

2011

  • Sociedade Espanhola de Química Terapêutica (SEQT) grant
    XVI Congreso de la SEQT – From a Classical to a New Age in Medicinal Chemistry, Valencia, Spain, 18-21th September, 2011
    Maria João Matos, University of Porto (Portugal)
    Webpage
  • Real Sociedad Española de Química grant
    VIII Simpósio Investigadores Jóvenes RSEQ- Sigma-Aldrich, Torremolinos, Málaga, 25-28th October, 2011
    Maria João Matos, University of Porto (Portugal)
    Webpage

2012

  • ADDF Young Investigator Scholarship grant from Alzheimer’s Drug Discovery Foundation
    6th Drug Discovery for Neurodegeneration conference: An intensive Course on Translating Research into Drugs, New York, USA, 12-14th February, 2012
    Alexandra Gaspar, University of Porto (Portugal)
    Joana Reis, University of Porto (Portugal)
    Tiago Silva, University of Porto (Portugal)
    José Teixeira, University of Porto (Portugal)
    Webpage

2013

  • Universidade de Santiago de Compostela grant
    Frontiers in Medicinal Chemistry, San Francisco, USA, 23-26th June, 2013
    Maria João Matos, University of Porto (Portugal)
    Webpage
  • Sociedade Espanhola de Química Terapêutica (SEQT)- 3rd Summer School:
    “Medicinal Chemistry in Drug Discovery: the Pharma Perspective, Madrid, Spain, 25-27 June, 2013
    Alexandra Gaspar, University of Porto (Portugal)
    Webpage
  • European Federation for Medicinal Chemistry (EFMC) fellowship
    European School of Medicinal Chemistry- ESMEC, Urbino, Italy, 26th June- 1st July, 2013
    Tiago Silva, University of Porto (Portugal)
    Webpage

2014

  • Sociedade Espanhola de Química Terapêutica (SEQT)- 4th GSK Summer School grant:
    “Medicinal Chemistry in Drug Discovery: the Pharma Perspective, Madrid, Spain, 25-27th June, 2014
    Salette Vasquez, University of Santiago Compostela (Spain)
    Webpage
  • European Federation for Medicinal Chemistry (EFMC) fellowship
    European School of Medicinal Chemistry- ESMEC, Urbino, Italy, 25-30th June, 2014
    Joana Reis, University of Porto (Portugal)
    Webpage
  • XXIII International Symposium on Medicinal Chemistry (EFMC-ISMC) grant
    Lisbon, Portugal, 7th-11nd September, 2014
    Maria João Matos, University of Porto (Portugal)
    Webpage
  • 10th Spanish-Italian Symposium on Organic Chemistry
    Firenze, Italy, 17-20 July, 2014
    Maria João Matos, University of Porto (Portugal)
    Webpage

2016

  • European Federation for Medicinal Chemistry (EFMC) fellowship
    European School of Medicinal Chemistry- ESMEC, Urbino, Italy, 26th June- 1st July, 2016
    Carlos Fernandes, University of Porto (Portugal)
    Webpage

2017

  • ITC Conference Grant from COST – (Action CA15135)
    7th meeting of Paul Ehrlich MedChem EuroPhD Network, Vienna, Austria, 25-27th August, 2017
    José Teixeira, University of Porto (Portugal)
    Webpage
  • MuTaLig COST Action (CA15135) – Short-Term Scientific Missions grant
    2017
    Joana Reis, University of Pavia (Italy) – 3 months
    Title: “Crystallographic and biochemical studies of multitarget chromone-based inhibitors of monoamine oxidase-B for the treatment of Alzheimer’s disease”

    Anabela Portela Borges, University of Cagliari (Italy) – 3 months
    Title: “In silico studies of new quorum-quenching compounds based on a brominated nitrovinylfuran to combat Pseudomonas aeruginosa infections”

    Webpage


2018

  • MuTaLig COST Action (CA15135) – Short-Term Scientific Missions grant
    2018
    Francesco Mesiti, University of Catanzaro (Italy) – 3 months
    Title:” Design and Development of Dual -Target Ligands Based on Benzopyran for the Treatment of Parkinson’s Disease”
    Webpage
  • 3rd MuTaLig COST Action Training School – MuTaLig COST Action, Fraunhofer IME Screening Port
    Hamburg, Germany, 5-7th December, 2018
    Sofia Benfeito, University of Porto (Portugal)
    Daniel Chavarria, University of Porto (Portugal)
    Catarina Oliveira, University of Porto (Portugal)
    Webpage

2019

  • 26th Young Research Fellows Meeting (YRFM)
    Paris, France, 20th-22nd February, 2019
    Daniel Chavarria, University of Porto (Portugal)
    Webpage
  • 3rd MuTaLig COST Action Training School – MuTaLig COST Action, Fraunhofer IME Screening Port
    2nd edition (EU), Hamburg, Germany, 6-8th March, 2019
    Tiago Silva, University of Porto (Portugal)
    Lisa Sequeira, University of Cagliari (Italy)
    Daniel Martins, University of Porto (Portugal)
    Miguel Pinto, University of Porto (Portugal)
    Francesco Mesiti, University of Catanzaro (Italy)
    Webpage